Due to their role in BRCA1/BRCA2 DNA repair pathway, the loss-of-function mutations of RAD51C, RAD51D, BRIP1, and BARD1 genes have been generally considered as ovarian cancer susceptibility genes. This evidence concerns the gene RAD51D and ovarian cancer.